ArticleAnnals of hematology2024

Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.

Aidan L Forberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.